Offer - Urjas Oil for just ₹ 1 X
Cabliz 0.5 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Acromegaly, Prolactinoma.
The optimal dosage of Cabliz 0.5 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Cabliz 0.5 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Cabliz 0.5 Tablet are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Cabliz 0.5 Tablet has a Mild effect for pregnant women and Severe effect on lactating mothers. Further, the section on Cabliz 0.5 Tablet related warnings talks about Cabliz 0.5 Tablet's effects on the liver, heart and kidney.
Cabliz 0.5 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Cabliz 0.5 Tablet in conditions like High Blood Pressure, Heart Disease, Depression. The section on Cabliz 0.5 Tablet contraindications lists all such conditions.
Drug reaction of Cabliz 0.5 Tablet with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Cabliz 0.5 Tablet is considered not safe while driving, and is not addictive.
Cabliz 0.5 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Cabliz 0.5 Tablet safe for pregnant women?
Cabliz has little to no side effects in pregnant women.
Is the use of Cabliz 0.5 Tablet safe during breastfeeding?
Taking Cabliz may lead to serious side effects if you are breastfeeding. Cabliz should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Cabliz 0.5 Tablet on the Kidneys?
There may be some adverse effects on kidney after taking Cabliz. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Cabliz 0.5 Tablet on the Liver?
You may experience side effects on your liver after taking Cabliz. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Cabliz 0.5 Tablet on the Heart?
Cabliz may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Cabliz 0.5 Tablet unless your doctor advises you to do so -
Is this Cabliz 0.5 Tablet habit forming or addictive?
Cabliz 0.5 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Cabliz 0.5 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Cabliz 0.5 Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Cabliz 0.5 Tablet in mental disorders is not effective.
Interaction between Food and Cabliz 0.5 Tablet
There is no information on the effects of taking Cabliz 0.5 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Cabliz 0.5 Tablet
Chances of side effects of drinking alcohol while taking Cabliz 0.5 Tablet are low. If you feel any adverse effects, please seek medical advice as soon as possible.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)